Celltrion signs $1.9B contract to supply COVID-19 test kits to US distributor

Celltrion USA signed a contract with Prime Healthcare Distributors to supply its Sampinute COVID-19 rapid antigen test kits across the United States. The deal is valued at 210 billion won (approximately $1.9 billion) and grants Prime Healthcare exclusive distribution rights.

“셀트리온 USA는 미국 프라임 헬스케어 디스트리뷰터스(Prime Healthcare Distributors)사와 2100억원 규모 코로나19 진단키트 공급 계약을 체결했다.”health.chosun.com

• 1 source
• health.chosun.com셀트리온, 美 전역에 코로나19 진단키트 공급…2100억 규모 계약 체결 - 헬스조선전종보 헬스조선Nov 2, 2020

Summarized from public sources; check the original articles before acting on it.